Global Autologous Biologics Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Autologous Biologics Industry Forecast” looks at past sales and reviews total world Autologous Biologics sales in 2022, providing a comprehensive analysis by region and market sector of projected Autologous Biologics sales for 2023 through 2029. With Autologous Biologics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Autologous Biologics industry.
This Insight Report provides a comprehensive analysis of the global Autologous Biologics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Autologous Biologics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Autologous Biologics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Autologous Biologics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Autologous Biologics.
The global Autologous Biologics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Autologous Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Autologous Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Autologous Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Autologous Biologics players cover Vericel Corporation, BioTime, Inc., Pharmicell Co., BrainStorm Cell Therapeutics, Opexa Therapeutics, Inc, Pharmicell Co., Inc, Neostem, Dendreon Corporation and Regenexx, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Autologous Biologics market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Autologous Biologics market?
What factors are driving Autologous Biologics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Autologous Biologics market opportunities vary by end market size?
How does Autologous Biologics break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Autologous Biologics Industry Forecast” looks at past sales and reviews total world Autologous Biologics sales in 2022, providing a comprehensive analysis by region and market sector of projected Autologous Biologics sales for 2023 through 2029. With Autologous Biologics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Autologous Biologics industry.
This Insight Report provides a comprehensive analysis of the global Autologous Biologics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Autologous Biologics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Autologous Biologics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Autologous Biologics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Autologous Biologics.
The global Autologous Biologics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Autologous Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Autologous Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Autologous Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Autologous Biologics players cover Vericel Corporation, BioTime, Inc., Pharmicell Co., BrainStorm Cell Therapeutics, Opexa Therapeutics, Inc, Pharmicell Co., Inc, Neostem, Dendreon Corporation and Regenexx, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Autologous Biologics market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Adipose Tissue
- Plasma
- Others
- Hospitals
- Ambulatory Centers
- Research Centers
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Vericel Corporation
- BioTime, Inc.
- Pharmicell Co.
- BrainStorm Cell Therapeutics
- Opexa Therapeutics, Inc
- Pharmicell Co., Inc
- Neostem
- Dendreon Corporation
- Regenexx
- Cytori Therapeutics
What is the 10-year outlook for the global Autologous Biologics market?
What factors are driving Autologous Biologics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Autologous Biologics market opportunities vary by end market size?
How does Autologous Biologics break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Autologous Biologics Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Autologous Biologics by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Autologous Biologics by Country/Region, 2018, 2022 & 2029
2.2 Autologous Biologics Segment by Type
2.2.1 Adipose Tissue
2.2.2 Plasma
2.2.3 Others
2.3 Autologous Biologics Sales by Type
2.3.1 Global Autologous Biologics Sales Market Share by Type (2018-2023)
2.3.2 Global Autologous Biologics Revenue and Market Share by Type (2018-2023)
2.3.3 Global Autologous Biologics Sale Price by Type (2018-2023)
2.4 Autologous Biologics Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Centers
2.4.3 Research Centers
2.5 Autologous Biologics Sales by Application
2.5.1 Global Autologous Biologics Sale Market Share by Application (2018-2023)
2.5.2 Global Autologous Biologics Revenue and Market Share by Application (2018-2023)
2.5.3 Global Autologous Biologics Sale Price by Application (2018-2023)
3 GLOBAL AUTOLOGOUS BIOLOGICS BY COMPANY
3.1 Global Autologous Biologics Breakdown Data by Company
3.1.1 Global Autologous Biologics Annual Sales by Company (2018-2023)
3.1.2 Global Autologous Biologics Sales Market Share by Company (2018-2023)
3.2 Global Autologous Biologics Annual Revenue by Company (2018-2023)
3.2.1 Global Autologous Biologics Revenue by Company (2018-2023)
3.2.2 Global Autologous Biologics Revenue Market Share by Company (2018-2023)
3.3 Global Autologous Biologics Sale Price by Company
3.4 Key Manufacturers Autologous Biologics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Autologous Biologics Product Location Distribution
3.4.2 Players Autologous Biologics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR AUTOLOGOUS BIOLOGICS BY GEOGRAPHIC REGION
4.1 World Historic Autologous Biologics Market Size by Geographic Region (2018-2023)
4.1.1 Global Autologous Biologics Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Autologous Biologics Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Autologous Biologics Market Size by Country/Region (2018-2023)
4.2.1 Global Autologous Biologics Annual Sales by Country/Region (2018-2023)
4.2.2 Global Autologous Biologics Annual Revenue by Country/Region (2018-2023)
4.3 Americas Autologous Biologics Sales Growth
4.4 APAC Autologous Biologics Sales Growth
4.5 Europe Autologous Biologics Sales Growth
4.6 Middle East & Africa Autologous Biologics Sales Growth
5 AMERICAS
5.1 Americas Autologous Biologics Sales by Country
5.1.1 Americas Autologous Biologics Sales by Country (2018-2023)
5.1.2 Americas Autologous Biologics Revenue by Country (2018-2023)
5.2 Americas Autologous Biologics Sales by Type
5.3 Americas Autologous Biologics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Autologous Biologics Sales by Region
6.1.1 APAC Autologous Biologics Sales by Region (2018-2023)
6.1.2 APAC Autologous Biologics Revenue by Region (2018-2023)
6.2 APAC Autologous Biologics Sales by Type
6.3 APAC Autologous Biologics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Autologous Biologics by Country
7.1.1 Europe Autologous Biologics Sales by Country (2018-2023)
7.1.2 Europe Autologous Biologics Revenue by Country (2018-2023)
7.2 Europe Autologous Biologics Sales by Type
7.3 Europe Autologous Biologics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Autologous Biologics by Country
8.1.1 Middle East & Africa Autologous Biologics Sales by Country (2018-2023)
8.1.2 Middle East & Africa Autologous Biologics Revenue by Country (2018-2023)
8.2 Middle East & Africa Autologous Biologics Sales by Type
8.3 Middle East & Africa Autologous Biologics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Autologous Biologics
10.3 Manufacturing Process Analysis of Autologous Biologics
10.4 Industry Chain Structure of Autologous Biologics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Autologous Biologics Distributors
11.3 Autologous Biologics Customer
12 WORLD FORECAST REVIEW FOR AUTOLOGOUS BIOLOGICS BY GEOGRAPHIC REGION
12.1 Global Autologous Biologics Market Size Forecast by Region
12.1.1 Global Autologous Biologics Forecast by Region (2024-2029)
12.1.2 Global Autologous Biologics Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Autologous Biologics Forecast by Type
12.7 Global Autologous Biologics Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Vericel Corporation
13.1.1 Vericel Corporation Company Information
13.1.2 Vericel Corporation Autologous Biologics Product Portfolios and Specifications
13.1.3 Vericel Corporation Autologous Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Vericel Corporation Main Business Overview
13.1.5 Vericel Corporation Latest Developments
13.2 BioTime, Inc.
13.2.1 BioTime, Inc. Company Information
13.2.2 BioTime, Inc. Autologous Biologics Product Portfolios and Specifications
13.2.3 BioTime, Inc. Autologous Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 BioTime, Inc. Main Business Overview
13.2.5 BioTime, Inc. Latest Developments
13.3 Pharmicell Co.
13.3.1 Pharmicell Co. Company Information
13.3.2 Pharmicell Co. Autologous Biologics Product Portfolios and Specifications
13.3.3 Pharmicell Co. Autologous Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pharmicell Co. Main Business Overview
13.3.5 Pharmicell Co. Latest Developments
13.4 BrainStorm Cell Therapeutics
13.4.1 BrainStorm Cell Therapeutics Company Information
13.4.2 BrainStorm Cell Therapeutics Autologous Biologics Product Portfolios and Specifications
13.4.3 BrainStorm Cell Therapeutics Autologous Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 BrainStorm Cell Therapeutics Main Business Overview
13.4.5 BrainStorm Cell Therapeutics Latest Developments
13.5 Opexa Therapeutics, Inc
13.5.1 Opexa Therapeutics, Inc Company Information
13.5.2 Opexa Therapeutics, Inc Autologous Biologics Product Portfolios and Specifications
13.5.3 Opexa Therapeutics, Inc Autologous Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Opexa Therapeutics, Inc Main Business Overview
13.5.5 Opexa Therapeutics, Inc Latest Developments
13.6 Pharmicell Co., Inc
13.6.1 Pharmicell Co., Inc Company Information
13.6.2 Pharmicell Co., Inc Autologous Biologics Product Portfolios and Specifications
13.6.3 Pharmicell Co., Inc Autologous Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Pharmicell Co., Inc Main Business Overview
13.6.5 Pharmicell Co., Inc Latest Developments
13.7 Neostem
13.7.1 Neostem Company Information
13.7.2 Neostem Autologous Biologics Product Portfolios and Specifications
13.7.3 Neostem Autologous Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Neostem Main Business Overview
13.7.5 Neostem Latest Developments
13.8 Dendreon Corporation
13.8.1 Dendreon Corporation Company Information
13.8.2 Dendreon Corporation Autologous Biologics Product Portfolios and Specifications
13.8.3 Dendreon Corporation Autologous Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Dendreon Corporation Main Business Overview
13.8.5 Dendreon Corporation Latest Developments
13.9 Regenexx
13.9.1 Regenexx Company Information
13.9.2 Regenexx Autologous Biologics Product Portfolios and Specifications
13.9.3 Regenexx Autologous Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Regenexx Main Business Overview
13.9.5 Regenexx Latest Developments
13.10 Cytori Therapeutics
13.10.1 Cytori Therapeutics Company Information
13.10.2 Cytori Therapeutics Autologous Biologics Product Portfolios and Specifications
13.10.3 Cytori Therapeutics Autologous Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Cytori Therapeutics Main Business Overview
13.10.5 Cytori Therapeutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Autologous Biologics Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Autologous Biologics by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Autologous Biologics by Country/Region, 2018, 2022 & 2029
2.2 Autologous Biologics Segment by Type
2.2.1 Adipose Tissue
2.2.2 Plasma
2.2.3 Others
2.3 Autologous Biologics Sales by Type
2.3.1 Global Autologous Biologics Sales Market Share by Type (2018-2023)
2.3.2 Global Autologous Biologics Revenue and Market Share by Type (2018-2023)
2.3.3 Global Autologous Biologics Sale Price by Type (2018-2023)
2.4 Autologous Biologics Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Centers
2.4.3 Research Centers
2.5 Autologous Biologics Sales by Application
2.5.1 Global Autologous Biologics Sale Market Share by Application (2018-2023)
2.5.2 Global Autologous Biologics Revenue and Market Share by Application (2018-2023)
2.5.3 Global Autologous Biologics Sale Price by Application (2018-2023)
3 GLOBAL AUTOLOGOUS BIOLOGICS BY COMPANY
3.1 Global Autologous Biologics Breakdown Data by Company
3.1.1 Global Autologous Biologics Annual Sales by Company (2018-2023)
3.1.2 Global Autologous Biologics Sales Market Share by Company (2018-2023)
3.2 Global Autologous Biologics Annual Revenue by Company (2018-2023)
3.2.1 Global Autologous Biologics Revenue by Company (2018-2023)
3.2.2 Global Autologous Biologics Revenue Market Share by Company (2018-2023)
3.3 Global Autologous Biologics Sale Price by Company
3.4 Key Manufacturers Autologous Biologics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Autologous Biologics Product Location Distribution
3.4.2 Players Autologous Biologics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR AUTOLOGOUS BIOLOGICS BY GEOGRAPHIC REGION
4.1 World Historic Autologous Biologics Market Size by Geographic Region (2018-2023)
4.1.1 Global Autologous Biologics Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Autologous Biologics Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Autologous Biologics Market Size by Country/Region (2018-2023)
4.2.1 Global Autologous Biologics Annual Sales by Country/Region (2018-2023)
4.2.2 Global Autologous Biologics Annual Revenue by Country/Region (2018-2023)
4.3 Americas Autologous Biologics Sales Growth
4.4 APAC Autologous Biologics Sales Growth
4.5 Europe Autologous Biologics Sales Growth
4.6 Middle East & Africa Autologous Biologics Sales Growth
5 AMERICAS
5.1 Americas Autologous Biologics Sales by Country
5.1.1 Americas Autologous Biologics Sales by Country (2018-2023)
5.1.2 Americas Autologous Biologics Revenue by Country (2018-2023)
5.2 Americas Autologous Biologics Sales by Type
5.3 Americas Autologous Biologics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Autologous Biologics Sales by Region
6.1.1 APAC Autologous Biologics Sales by Region (2018-2023)
6.1.2 APAC Autologous Biologics Revenue by Region (2018-2023)
6.2 APAC Autologous Biologics Sales by Type
6.3 APAC Autologous Biologics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Autologous Biologics by Country
7.1.1 Europe Autologous Biologics Sales by Country (2018-2023)
7.1.2 Europe Autologous Biologics Revenue by Country (2018-2023)
7.2 Europe Autologous Biologics Sales by Type
7.3 Europe Autologous Biologics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Autologous Biologics by Country
8.1.1 Middle East & Africa Autologous Biologics Sales by Country (2018-2023)
8.1.2 Middle East & Africa Autologous Biologics Revenue by Country (2018-2023)
8.2 Middle East & Africa Autologous Biologics Sales by Type
8.3 Middle East & Africa Autologous Biologics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Autologous Biologics
10.3 Manufacturing Process Analysis of Autologous Biologics
10.4 Industry Chain Structure of Autologous Biologics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Autologous Biologics Distributors
11.3 Autologous Biologics Customer
12 WORLD FORECAST REVIEW FOR AUTOLOGOUS BIOLOGICS BY GEOGRAPHIC REGION
12.1 Global Autologous Biologics Market Size Forecast by Region
12.1.1 Global Autologous Biologics Forecast by Region (2024-2029)
12.1.2 Global Autologous Biologics Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Autologous Biologics Forecast by Type
12.7 Global Autologous Biologics Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Vericel Corporation
13.1.1 Vericel Corporation Company Information
13.1.2 Vericel Corporation Autologous Biologics Product Portfolios and Specifications
13.1.3 Vericel Corporation Autologous Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Vericel Corporation Main Business Overview
13.1.5 Vericel Corporation Latest Developments
13.2 BioTime, Inc.
13.2.1 BioTime, Inc. Company Information
13.2.2 BioTime, Inc. Autologous Biologics Product Portfolios and Specifications
13.2.3 BioTime, Inc. Autologous Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 BioTime, Inc. Main Business Overview
13.2.5 BioTime, Inc. Latest Developments
13.3 Pharmicell Co.
13.3.1 Pharmicell Co. Company Information
13.3.2 Pharmicell Co. Autologous Biologics Product Portfolios and Specifications
13.3.3 Pharmicell Co. Autologous Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pharmicell Co. Main Business Overview
13.3.5 Pharmicell Co. Latest Developments
13.4 BrainStorm Cell Therapeutics
13.4.1 BrainStorm Cell Therapeutics Company Information
13.4.2 BrainStorm Cell Therapeutics Autologous Biologics Product Portfolios and Specifications
13.4.3 BrainStorm Cell Therapeutics Autologous Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 BrainStorm Cell Therapeutics Main Business Overview
13.4.5 BrainStorm Cell Therapeutics Latest Developments
13.5 Opexa Therapeutics, Inc
13.5.1 Opexa Therapeutics, Inc Company Information
13.5.2 Opexa Therapeutics, Inc Autologous Biologics Product Portfolios and Specifications
13.5.3 Opexa Therapeutics, Inc Autologous Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Opexa Therapeutics, Inc Main Business Overview
13.5.5 Opexa Therapeutics, Inc Latest Developments
13.6 Pharmicell Co., Inc
13.6.1 Pharmicell Co., Inc Company Information
13.6.2 Pharmicell Co., Inc Autologous Biologics Product Portfolios and Specifications
13.6.3 Pharmicell Co., Inc Autologous Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Pharmicell Co., Inc Main Business Overview
13.6.5 Pharmicell Co., Inc Latest Developments
13.7 Neostem
13.7.1 Neostem Company Information
13.7.2 Neostem Autologous Biologics Product Portfolios and Specifications
13.7.3 Neostem Autologous Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Neostem Main Business Overview
13.7.5 Neostem Latest Developments
13.8 Dendreon Corporation
13.8.1 Dendreon Corporation Company Information
13.8.2 Dendreon Corporation Autologous Biologics Product Portfolios and Specifications
13.8.3 Dendreon Corporation Autologous Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Dendreon Corporation Main Business Overview
13.8.5 Dendreon Corporation Latest Developments
13.9 Regenexx
13.9.1 Regenexx Company Information
13.9.2 Regenexx Autologous Biologics Product Portfolios and Specifications
13.9.3 Regenexx Autologous Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Regenexx Main Business Overview
13.9.5 Regenexx Latest Developments
13.10 Cytori Therapeutics
13.10.1 Cytori Therapeutics Company Information
13.10.2 Cytori Therapeutics Autologous Biologics Product Portfolios and Specifications
13.10.3 Cytori Therapeutics Autologous Biologics Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Cytori Therapeutics Main Business Overview
13.10.5 Cytori Therapeutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Autologous Biologics Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Autologous Biologics Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Adipose Tissue
Table 4. Major Players of Plasma
Table 5. Major Players of Others
Table 6. Global Autologous Biologics Sales by Type (2018-2023) & (Kg)
Table 7. Global Autologous Biologics Sales Market Share by Type (2018-2023)
Table 8. Global Autologous Biologics Revenue by Type (2018-2023) & ($ million)
Table 9. Global Autologous Biologics Revenue Market Share by Type (2018-2023)
Table 10. Global Autologous Biologics Sale Price by Type (2018-2023) & (US$/Kg)
Table 11. Global Autologous Biologics Sales by Application (2018-2023) & (Kg)
Table 12. Global Autologous Biologics Sales Market Share by Application (2018-2023)
Table 13. Global Autologous Biologics Revenue by Application (2018-2023)
Table 14. Global Autologous Biologics Revenue Market Share by Application (2018-2023)
Table 15. Global Autologous Biologics Sale Price by Application (2018-2023) & (US$/Kg)
Table 16. Global Autologous Biologics Sales by Company (2018-2023) & (Kg)
Table 17. Global Autologous Biologics Sales Market Share by Company (2018-2023)
Table 18. Global Autologous Biologics Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Autologous Biologics Revenue Market Share by Company (2018-2023)
Table 20. Global Autologous Biologics Sale Price by Company (2018-2023) & (US$/Kg)
Table 21. Key Manufacturers Autologous Biologics Producing Area Distribution and Sales Area
Table 22. Players Autologous Biologics Products Offered
Table 23. Autologous Biologics Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Autologous Biologics Sales by Geographic Region (2018-2023) & (Kg)
Table 27. Global Autologous Biologics Sales Market Share Geographic Region (2018-2023)
Table 28. Global Autologous Biologics Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Autologous Biologics Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Autologous Biologics Sales by Country/Region (2018-2023) & (Kg)
Table 31. Global Autologous Biologics Sales Market Share by Country/Region (2018-2023)
Table 32. Global Autologous Biologics Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Autologous Biologics Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Autologous Biologics Sales by Country (2018-2023) & (Kg)
Table 35. Americas Autologous Biologics Sales Market Share by Country (2018-2023)
Table 36. Americas Autologous Biologics Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Autologous Biologics Revenue Market Share by Country (2018-2023)
Table 38. Americas Autologous Biologics Sales by Type (2018-2023) & (Kg)
Table 39. Americas Autologous Biologics Sales by Application (2018-2023) & (Kg)
Table 40. APAC Autologous Biologics Sales by Region (2018-2023) & (Kg)
Table 41. APAC Autologous Biologics Sales Market Share by Region (2018-2023)
Table 42. APAC Autologous Biologics Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Autologous Biologics Revenue Market Share by Region (2018-2023)
Table 44. APAC Autologous Biologics Sales by Type (2018-2023) & (Kg)
Table 45. APAC Autologous Biologics Sales by Application (2018-2023) & (Kg)
Table 46. Europe Autologous Biologics Sales by Country (2018-2023) & (Kg)
Table 47. Europe Autologous Biologics Sales Market Share by Country (2018-2023)
Table 48. Europe Autologous Biologics Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Autologous Biologics Revenue Market Share by Country (2018-2023)
Table 50. Europe Autologous Biologics Sales by Type (2018-2023) & (Kg)
Table 51. Europe Autologous Biologics Sales by Application (2018-2023) & (Kg)
Table 52. Middle East & Africa Autologous Biologics Sales by Country (2018-2023) & (Kg)
Table 53. Middle East & Africa Autologous Biologics Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Autologous Biologics Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Autologous Biologics Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Autologous Biologics Sales by Type (2018-2023) & (Kg)
Table 57. Middle East & Africa Autologous Biologics Sales by Application (2018-2023) & (Kg)
Table 58. Key Market Drivers & Growth Opportunities of Autologous Biologics
Table 59. Key Market Challenges & Risks of Autologous Biologics
Table 60. Key Industry Trends of Autologous Biologics
Table 61. Autologous Biologics Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Autologous Biologics Distributors List
Table 64. Autologous Biologics Customer List
Table 65. Global Autologous Biologics Sales Forecast by Region (2024-2029) & (Kg)
Table 66. Global Autologous Biologics Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Autologous Biologics Sales Forecast by Country (2024-2029) & (Kg)
Table 68. Americas Autologous Biologics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Autologous Biologics Sales Forecast by Region (2024-2029) & (Kg)
Table 70. APAC Autologous Biologics Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Autologous Biologics Sales Forecast by Country (2024-2029) & (Kg)
Table 72. Europe Autologous Biologics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Autologous Biologics Sales Forecast by Country (2024-2029) & (Kg)
Table 74. Middle East & Africa Autologous Biologics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Autologous Biologics Sales Forecast by Type (2024-2029) & (Kg)
Table 76. Global Autologous Biologics Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Autologous Biologics Sales Forecast by Application (2024-2029) & (Kg)
Table 78. Global Autologous Biologics Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Vericel Corporation Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 80. Vericel Corporation Autologous Biologics Product Portfolios and Specifications
Table 81. Vericel Corporation Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 82. Vericel Corporation Main Business
Table 83. Vericel Corporation Latest Developments
Table 84. BioTime, Inc. Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 85. BioTime, Inc. Autologous Biologics Product Portfolios and Specifications
Table 86. BioTime, Inc. Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 87. BioTime, Inc. Main Business
Table 88. BioTime, Inc. Latest Developments
Table 89. Pharmicell Co. Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 90. Pharmicell Co. Autologous Biologics Product Portfolios and Specifications
Table 91. Pharmicell Co. Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 92. Pharmicell Co. Main Business
Table 93. Pharmicell Co. Latest Developments
Table 94. BrainStorm Cell Therapeutics Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 95. BrainStorm Cell Therapeutics Autologous Biologics Product Portfolios and Specifications
Table 96. BrainStorm Cell Therapeutics Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 97. BrainStorm Cell Therapeutics Main Business
Table 98. BrainStorm Cell Therapeutics Latest Developments
Table 99. Opexa Therapeutics, Inc Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 100. Opexa Therapeutics, Inc Autologous Biologics Product Portfolios and Specifications
Table 101. Opexa Therapeutics, Inc Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 102. Opexa Therapeutics, Inc Main Business
Table 103. Opexa Therapeutics, Inc Latest Developments
Table 104. Pharmicell Co., Inc Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 105. Pharmicell Co., Inc Autologous Biologics Product Portfolios and Specifications
Table 106. Pharmicell Co., Inc Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 107. Pharmicell Co., Inc Main Business
Table 108. Pharmicell Co., Inc Latest Developments
Table 109. Neostem Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 110. Neostem Autologous Biologics Product Portfolios and Specifications
Table 111. Neostem Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 112. Neostem Main Business
Table 113. Neostem Latest Developments
Table 114. Dendreon Corporation Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 115. Dendreon Corporation Autologous Biologics Product Portfolios and Specifications
Table 116. Dendreon Corporation Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 117. Dendreon Corporation Main Business
Table 118. Dendreon Corporation Latest Developments
Table 119. Regenexx Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 120. Regenexx Autologous Biologics Product Portfolios and Specifications
Table 121. Regenexx Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 122. Regenexx Main Business
Table 123. Regenexx Latest Developments
Table 124. Cytori Therapeutics Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 125. Cytori Therapeutics Autologous Biologics Product Portfolios and Specifications
Table 126. Cytori Therapeutics Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 127. Cytori Therapeutics Main Business
Table 128. Cytori Therapeutics Latest Developments
Table 1. Autologous Biologics Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Autologous Biologics Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Adipose Tissue
Table 4. Major Players of Plasma
Table 5. Major Players of Others
Table 6. Global Autologous Biologics Sales by Type (2018-2023) & (Kg)
Table 7. Global Autologous Biologics Sales Market Share by Type (2018-2023)
Table 8. Global Autologous Biologics Revenue by Type (2018-2023) & ($ million)
Table 9. Global Autologous Biologics Revenue Market Share by Type (2018-2023)
Table 10. Global Autologous Biologics Sale Price by Type (2018-2023) & (US$/Kg)
Table 11. Global Autologous Biologics Sales by Application (2018-2023) & (Kg)
Table 12. Global Autologous Biologics Sales Market Share by Application (2018-2023)
Table 13. Global Autologous Biologics Revenue by Application (2018-2023)
Table 14. Global Autologous Biologics Revenue Market Share by Application (2018-2023)
Table 15. Global Autologous Biologics Sale Price by Application (2018-2023) & (US$/Kg)
Table 16. Global Autologous Biologics Sales by Company (2018-2023) & (Kg)
Table 17. Global Autologous Biologics Sales Market Share by Company (2018-2023)
Table 18. Global Autologous Biologics Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Autologous Biologics Revenue Market Share by Company (2018-2023)
Table 20. Global Autologous Biologics Sale Price by Company (2018-2023) & (US$/Kg)
Table 21. Key Manufacturers Autologous Biologics Producing Area Distribution and Sales Area
Table 22. Players Autologous Biologics Products Offered
Table 23. Autologous Biologics Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Autologous Biologics Sales by Geographic Region (2018-2023) & (Kg)
Table 27. Global Autologous Biologics Sales Market Share Geographic Region (2018-2023)
Table 28. Global Autologous Biologics Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Autologous Biologics Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Autologous Biologics Sales by Country/Region (2018-2023) & (Kg)
Table 31. Global Autologous Biologics Sales Market Share by Country/Region (2018-2023)
Table 32. Global Autologous Biologics Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Autologous Biologics Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Autologous Biologics Sales by Country (2018-2023) & (Kg)
Table 35. Americas Autologous Biologics Sales Market Share by Country (2018-2023)
Table 36. Americas Autologous Biologics Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Autologous Biologics Revenue Market Share by Country (2018-2023)
Table 38. Americas Autologous Biologics Sales by Type (2018-2023) & (Kg)
Table 39. Americas Autologous Biologics Sales by Application (2018-2023) & (Kg)
Table 40. APAC Autologous Biologics Sales by Region (2018-2023) & (Kg)
Table 41. APAC Autologous Biologics Sales Market Share by Region (2018-2023)
Table 42. APAC Autologous Biologics Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Autologous Biologics Revenue Market Share by Region (2018-2023)
Table 44. APAC Autologous Biologics Sales by Type (2018-2023) & (Kg)
Table 45. APAC Autologous Biologics Sales by Application (2018-2023) & (Kg)
Table 46. Europe Autologous Biologics Sales by Country (2018-2023) & (Kg)
Table 47. Europe Autologous Biologics Sales Market Share by Country (2018-2023)
Table 48. Europe Autologous Biologics Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Autologous Biologics Revenue Market Share by Country (2018-2023)
Table 50. Europe Autologous Biologics Sales by Type (2018-2023) & (Kg)
Table 51. Europe Autologous Biologics Sales by Application (2018-2023) & (Kg)
Table 52. Middle East & Africa Autologous Biologics Sales by Country (2018-2023) & (Kg)
Table 53. Middle East & Africa Autologous Biologics Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Autologous Biologics Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Autologous Biologics Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Autologous Biologics Sales by Type (2018-2023) & (Kg)
Table 57. Middle East & Africa Autologous Biologics Sales by Application (2018-2023) & (Kg)
Table 58. Key Market Drivers & Growth Opportunities of Autologous Biologics
Table 59. Key Market Challenges & Risks of Autologous Biologics
Table 60. Key Industry Trends of Autologous Biologics
Table 61. Autologous Biologics Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Autologous Biologics Distributors List
Table 64. Autologous Biologics Customer List
Table 65. Global Autologous Biologics Sales Forecast by Region (2024-2029) & (Kg)
Table 66. Global Autologous Biologics Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Autologous Biologics Sales Forecast by Country (2024-2029) & (Kg)
Table 68. Americas Autologous Biologics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Autologous Biologics Sales Forecast by Region (2024-2029) & (Kg)
Table 70. APAC Autologous Biologics Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Autologous Biologics Sales Forecast by Country (2024-2029) & (Kg)
Table 72. Europe Autologous Biologics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Autologous Biologics Sales Forecast by Country (2024-2029) & (Kg)
Table 74. Middle East & Africa Autologous Biologics Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Autologous Biologics Sales Forecast by Type (2024-2029) & (Kg)
Table 76. Global Autologous Biologics Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Autologous Biologics Sales Forecast by Application (2024-2029) & (Kg)
Table 78. Global Autologous Biologics Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Vericel Corporation Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 80. Vericel Corporation Autologous Biologics Product Portfolios and Specifications
Table 81. Vericel Corporation Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 82. Vericel Corporation Main Business
Table 83. Vericel Corporation Latest Developments
Table 84. BioTime, Inc. Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 85. BioTime, Inc. Autologous Biologics Product Portfolios and Specifications
Table 86. BioTime, Inc. Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 87. BioTime, Inc. Main Business
Table 88. BioTime, Inc. Latest Developments
Table 89. Pharmicell Co. Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 90. Pharmicell Co. Autologous Biologics Product Portfolios and Specifications
Table 91. Pharmicell Co. Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 92. Pharmicell Co. Main Business
Table 93. Pharmicell Co. Latest Developments
Table 94. BrainStorm Cell Therapeutics Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 95. BrainStorm Cell Therapeutics Autologous Biologics Product Portfolios and Specifications
Table 96. BrainStorm Cell Therapeutics Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 97. BrainStorm Cell Therapeutics Main Business
Table 98. BrainStorm Cell Therapeutics Latest Developments
Table 99. Opexa Therapeutics, Inc Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 100. Opexa Therapeutics, Inc Autologous Biologics Product Portfolios and Specifications
Table 101. Opexa Therapeutics, Inc Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 102. Opexa Therapeutics, Inc Main Business
Table 103. Opexa Therapeutics, Inc Latest Developments
Table 104. Pharmicell Co., Inc Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 105. Pharmicell Co., Inc Autologous Biologics Product Portfolios and Specifications
Table 106. Pharmicell Co., Inc Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 107. Pharmicell Co., Inc Main Business
Table 108. Pharmicell Co., Inc Latest Developments
Table 109. Neostem Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 110. Neostem Autologous Biologics Product Portfolios and Specifications
Table 111. Neostem Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 112. Neostem Main Business
Table 113. Neostem Latest Developments
Table 114. Dendreon Corporation Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 115. Dendreon Corporation Autologous Biologics Product Portfolios and Specifications
Table 116. Dendreon Corporation Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 117. Dendreon Corporation Main Business
Table 118. Dendreon Corporation Latest Developments
Table 119. Regenexx Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 120. Regenexx Autologous Biologics Product Portfolios and Specifications
Table 121. Regenexx Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 122. Regenexx Main Business
Table 123. Regenexx Latest Developments
Table 124. Cytori Therapeutics Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 125. Cytori Therapeutics Autologous Biologics Product Portfolios and Specifications
Table 126. Cytori Therapeutics Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 127. Cytori Therapeutics Main Business
Table 128. Cytori Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. Picture of Autologous Biologics
Figure 2. Autologous Biologics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Autologous Biologics Sales Growth Rate 2018-2029 (Kg)
Figure 7. Global Autologous Biologics Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Autologous Biologics Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Adipose Tissue
Figure 10. Product Picture of Plasma
Figure 11. Product Picture of Others
Figure 12. Global Autologous Biologics Sales Market Share by Type in 2022
Figure 13. Global Autologous Biologics Revenue Market Share by Type (2018-2023)
Figure 14. Autologous Biologics Consumed in Hospitals
Figure 15. Global Autologous Biologics Market: Hospitals (2018-2023) & (Kg)
Figure 16. Autologous Biologics Consumed in Ambulatory Centers
Figure 17. Global Autologous Biologics Market: Ambulatory Centers (2018-2023) & (Kg)
Figure 18. Autologous Biologics Consumed in Research Centers
Figure 19. Global Autologous Biologics Market: Research Centers (2018-2023) & (Kg)
Figure 20. Global Autologous Biologics Sales Market Share by Application (2022)
Figure 21. Global Autologous Biologics Revenue Market Share by Application in 2022
Figure 22. Autologous Biologics Sales Market by Company in 2022 (Kg)
Figure 23. Global Autologous Biologics Sales Market Share by Company in 2022
Figure 24. Autologous Biologics Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Autologous Biologics Revenue Market Share by Company in 2022
Figure 26. Global Autologous Biologics Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Autologous Biologics Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Autologous Biologics Sales 2018-2023 (Kg)
Figure 29. Americas Autologous Biologics Revenue 2018-2023 ($ Millions)
Figure 30. APAC Autologous Biologics Sales 2018-2023 (Kg)
Figure 31. APAC Autologous Biologics Revenue 2018-2023 ($ Millions)
Figure 32. Europe Autologous Biologics Sales 2018-2023 (Kg)
Figure 33. Europe Autologous Biologics Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Autologous Biologics Sales 2018-2023 (Kg)
Figure 35. Middle East & Africa Autologous Biologics Revenue 2018-2023 ($ Millions)
Figure 36. Americas Autologous Biologics Sales Market Share by Country in 2022
Figure 37. Americas Autologous Biologics Revenue Market Share by Country in 2022
Figure 38. Americas Autologous Biologics Sales Market Share by Type (2018-2023)
Figure 39. Americas Autologous Biologics Sales Market Share by Application (2018-2023)
Figure 40. United States Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Autologous Biologics Sales Market Share by Region in 2022
Figure 45. APAC Autologous Biologics Revenue Market Share by Regions in 2022
Figure 46. APAC Autologous Biologics Sales Market Share by Type (2018-2023)
Figure 47. APAC Autologous Biologics Sales Market Share by Application (2018-2023)
Figure 48. China Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Autologous Biologics Sales Market Share by Country in 2022
Figure 56. Europe Autologous Biologics Revenue Market Share by Country in 2022
Figure 57. Europe Autologous Biologics Sales Market Share by Type (2018-2023)
Figure 58. Europe Autologous Biologics Sales Market Share by Application (2018-2023)
Figure 59. Germany Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Autologous Biologics Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Autologous Biologics Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Autologous Biologics Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Autologous Biologics Sales Market Share by Application (2018-2023)
Figure 68. Egypt Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Autologous Biologics in 2022
Figure 74. Manufacturing Process Analysis of Autologous Biologics
Figure 75. Industry Chain Structure of Autologous Biologics
Figure 76. Channels of Distribution
Figure 77. Global Autologous Biologics Sales Market Forecast by Region (2024-2029)
Figure 78. Global Autologous Biologics Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Autologous Biologics Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Autologous Biologics Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Autologous Biologics Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Autologous Biologics Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Autologous Biologics
Figure 2. Autologous Biologics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Autologous Biologics Sales Growth Rate 2018-2029 (Kg)
Figure 7. Global Autologous Biologics Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Autologous Biologics Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Adipose Tissue
Figure 10. Product Picture of Plasma
Figure 11. Product Picture of Others
Figure 12. Global Autologous Biologics Sales Market Share by Type in 2022
Figure 13. Global Autologous Biologics Revenue Market Share by Type (2018-2023)
Figure 14. Autologous Biologics Consumed in Hospitals
Figure 15. Global Autologous Biologics Market: Hospitals (2018-2023) & (Kg)
Figure 16. Autologous Biologics Consumed in Ambulatory Centers
Figure 17. Global Autologous Biologics Market: Ambulatory Centers (2018-2023) & (Kg)
Figure 18. Autologous Biologics Consumed in Research Centers
Figure 19. Global Autologous Biologics Market: Research Centers (2018-2023) & (Kg)
Figure 20. Global Autologous Biologics Sales Market Share by Application (2022)
Figure 21. Global Autologous Biologics Revenue Market Share by Application in 2022
Figure 22. Autologous Biologics Sales Market by Company in 2022 (Kg)
Figure 23. Global Autologous Biologics Sales Market Share by Company in 2022
Figure 24. Autologous Biologics Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Autologous Biologics Revenue Market Share by Company in 2022
Figure 26. Global Autologous Biologics Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Autologous Biologics Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Autologous Biologics Sales 2018-2023 (Kg)
Figure 29. Americas Autologous Biologics Revenue 2018-2023 ($ Millions)
Figure 30. APAC Autologous Biologics Sales 2018-2023 (Kg)
Figure 31. APAC Autologous Biologics Revenue 2018-2023 ($ Millions)
Figure 32. Europe Autologous Biologics Sales 2018-2023 (Kg)
Figure 33. Europe Autologous Biologics Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Autologous Biologics Sales 2018-2023 (Kg)
Figure 35. Middle East & Africa Autologous Biologics Revenue 2018-2023 ($ Millions)
Figure 36. Americas Autologous Biologics Sales Market Share by Country in 2022
Figure 37. Americas Autologous Biologics Revenue Market Share by Country in 2022
Figure 38. Americas Autologous Biologics Sales Market Share by Type (2018-2023)
Figure 39. Americas Autologous Biologics Sales Market Share by Application (2018-2023)
Figure 40. United States Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Autologous Biologics Sales Market Share by Region in 2022
Figure 45. APAC Autologous Biologics Revenue Market Share by Regions in 2022
Figure 46. APAC Autologous Biologics Sales Market Share by Type (2018-2023)
Figure 47. APAC Autologous Biologics Sales Market Share by Application (2018-2023)
Figure 48. China Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Autologous Biologics Sales Market Share by Country in 2022
Figure 56. Europe Autologous Biologics Revenue Market Share by Country in 2022
Figure 57. Europe Autologous Biologics Sales Market Share by Type (2018-2023)
Figure 58. Europe Autologous Biologics Sales Market Share by Application (2018-2023)
Figure 59. Germany Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Autologous Biologics Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Autologous Biologics Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Autologous Biologics Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Autologous Biologics Sales Market Share by Application (2018-2023)
Figure 68. Egypt Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Autologous Biologics Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Autologous Biologics in 2022
Figure 74. Manufacturing Process Analysis of Autologous Biologics
Figure 75. Industry Chain Structure of Autologous Biologics
Figure 76. Channels of Distribution
Figure 77. Global Autologous Biologics Sales Market Forecast by Region (2024-2029)
Figure 78. Global Autologous Biologics Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Autologous Biologics Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Autologous Biologics Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Autologous Biologics Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Autologous Biologics Revenue Market Share Forecast by Application (2024-2029)
